About The Study: The results this cohort study suggest that children ages 7 to 17 with metabolically healthy obesity at treatment initiation have an increased associated long-term risk of type 2 diabetes, hypertension, and dyslipidemia compared with their peers in the general population. Reduction in BMI z score in pediatric obesity treatment was associated with reduced cardiometabolic risk in children with metabolically healthy and unhealthy obesity to the same extent. Therefore, treatment should also be recommended for children with obesity who appear metabolically healthy.
Corresponding Author: To contact the corresponding author, Emilia Hagman, PhD, email emilia.hagman@ki.se.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2026.0343)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.0343?guestAccessKey=b1c10486-dc83-4ab8-bc7e-25352b86ba36&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032326
Journal
JAMA Pediatrics